RM Global Health

www.rmgh.net

 
  • Increase font size
  • Default font size
  • Decrease font size
  • default color
  • green color
  • blue color

Merck Recalls 3 Lots Of Invanz

Saturday, 18 August 2007 18:56 Ramaz Mitaishvili
E-mail Print PDF
{mosimage}FDA - MedWatch - Merck Recalls 3 Lots Of Invanz (ertapenem sodium) Injection Because The Product May Contain Broken Glass Pieces In The Reconstituted Solution For Injection MedWatch - The FDA Safety Information and Adverse Event Reporting Program

Merck and FDA informed healthcare professionals that 3 lots of Invanz (0803930, 0803940, and 0803950), a product indicated for the treatment of patients with moderate to severe infections caused by susceptible isolates of the designated microorganisms, were recalled. The product was recalled because of two incidents of finding broken glass pieces in the reconstituted solution for injection. Healthcare professionals are advised to immediately stop dispensing all products from the three lots specified above. No other lots are affected by this recall.
Last Updated ( Monday, 11 February 2008 19:56 )  
Malaria
Malaria Awareness
Malaria kills more than 1 million people each year. Most are young children in sub-Saharan Africa. "Free Africa from Malaria Now" is the theme of Africa Malaria Day, April 25, which this year marks also the first US Malaria Awareness Day.

Alerts

Can Pharmacists Improve the Accuracy of Medication Histories? Can Pharmacists Improve the Accuracy of Medication Histories? Reviewed by Ramaz Mitaishvili, MD 
 
Byetta Linked to Acute Pancreatitis Six new cases of hemorrhagic or necrotizing pancreatitis have been reported in patients using exenatide injection (Byett...
 
Why Should I Report an Adverse Drug Event? When I was in charge of the postmarketing drug safety program at the US Food and Drug Administration (FDA) in the early ...